Healthcare -
Biotechnology - NASDAQ - US
$ 1.2229
-0.84 %
$ 18.5 M
Market Cap
-0.87
P/E
LGVN - STOCK-BASED COMPENSATION
Stock-based Compensation LGVN - Longeveron Inc.
2.33 M
LAST VALUE
3.65%
2 YEAR CAGR
76.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR